Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a serious global health problem in the 21st century because of its high mortality. Mtb is an extremely successful human-adapted pathogen that displays a multifactorial ability to control the host immune response and to evade killing by drugs, resulting in the breakdown of BCG vaccine-conferred anti-TB immunity and development of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mtb. Although genetic components of the genomes of the Mtb complex strains are highly conserved, showing over 99% similarity to other bacterial genera, recently accumulated evidence suggests that the genetic diversity of the Mtb complex strains has implications for treatment outcomes, development of MDR/XDR Mtb, BCG vaccine efficacy, transmissibility, and epidemiological outbreaks. Thus, new insights into the pathophysiological features of the Mtb complex strains are required for development of novel vaccines and for control of MDR/XDR Mtb infection, eventually leading to refinement of treatment regimens and the health care system. Many studies have focused on the differential identification of Mtb complex strains belonging to different lineages because of differences in their virulence and geographical dominance. In this review, we discuss the impact of differing genetic characteristics among Mtb complex strains on vaccine efficacy, treatment outcome, development of MDR/XDR Mtb strains, and epidemiological outbreaks by focusing on the best-adapted human Mtb lineages. We further explore the rationale for differential identification of Mtb strains for more effective control of TB in clinical and laboratory settings by scrutinizing current diagnostic methods.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abebe, F. and Bjune, G. 2006. The emergence of Bei**g family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: Is there a link? Clin. Exp. Immunol. 145, 389–397.
Achtman, M. 2008. Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu. Rev. Microbiol. 62, 53–70.
Agerton, T.B., Valway, S.E., Blinkhorn, R.J., Shilkret, K.L., Reves, R., Schluter, W.W., Gore, B., Pozsik, C.J., Plikaytis, B.B., Woodley, C., et al. 1999. Spread of strain w, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin. Infect. Dis. 29, 85–92; discussion 93–85.
Barczak, A.K., Domenech, P., Boshoff, H.I., Reed, M.B., Manca, C., Kaplan, G., and Barry, C.E. 3rd. 2005. In vivo phenotypic dominance in mouse mixed infections with Mycobacterium tuberculosis clinical isolates. J. Infect. Dis. 192, 600–606.
Bifani, P.J., Mathema, B., Kurepina, N.E., and Kreiswirth, B.N. 2002. Global dissemination of the Mycobacterium tuberculosis W-bei**g family strains. Trends Microbiol. 10, 45–52.
Brosch, R., Gordon, S.V., Marmiesse, M., Brodin, P., Buchrieser, C., Eiglmeier, K., Garnier, T., Gutierrez, C., Hewinson, G., Kremer, K., et al. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 99, 3684–3689.
Brudey, K., Driscoll, J.R., Rigouts, L., Prodinger, W.M., Gori, A., Al- Hajoj, S.A., Allix, C., Aristimuno, L., Arora, J., Baumanis, V., et al. 2006. Mycobacterium tuberculosis complex genetic diversity: Mining the fourth international spoligoty** database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 6, 23.
Buu, T.N., van Soolingen, D., Huyen, M.N., Lan, N.T., Quy, H.T., Tiemersma, E.W., Kremer, K., Borgdorff, M.W., and Cobelens, F.G. 2012. Increased transmission of Mycobacterium tuberculosis bei**g genotype strains associated with resistance to streptomycin: A population-based study. PLoS One 7, e42323.
Casali, N., Nikolayevskyy, V., Balabanova, Y., Harris, S.R., Ignatyeva, O., Kontsevaya, I., Corander, J., Bryant, J., Parkhill, J., Nejentsev, S., et al. 2014. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat. Genet. 46, 279–286.
Chae, H., Han, S.J., Kim, S.Y., Ki, C.S., Huh, H.J., Yong, D., Koh, W.J., and Shin, S.J. 2017. Development of a one-step multiplex PCR assay for differential detection of major Mycobacterium species. J. Clin. Microbiol. 55, 2736–2751.
Cohen, K.A., Abeel, T., Manson McGuire, A., Desjardins, C.A., Munsamy, V., Shea, T.P., Walker, B.J., Bantubani, N., Almeida, D.V., Alvarado, L., et al. 2015. Evolution of extensively drug-resistant tuberculosis over four decades: Whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from Kwa-Zulu-Natal. PLoS Med. 12, e1001880.
Cole, S.T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S.V., Eiglmeier, K., Gas, S., Barry, C.E. 3rd, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537–544.
Coll, F., McNerney, R., Guerra-Assuncao, J.A., Glynn, J.R., Perdigao, J., Viveiros, M., Portugal, I., Pain, A., Martin, N., and Clark, T.G. 2014. A robust SNP barcode for ty** Mycobacterium tuberculosis complex strains. Nat. Commun. 5, 4812.
Comas, I. and Gagneux, S. 2011. A role for systems epidemiology in tuberculosis research. Trends Microbiol. 19, 492–500.
Comas, I., Homolka, S., Niemann, S., and Gagneux, S. 2009. Genoty** of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS One 4, e7815.
Coscolla, M. and Gagneux, S. 2010. Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov. Today Dis. Mech. 7, e43–e59.
Coscolla, M. and Gagneux, S. 2014. Consequences of genomic diversity in Mycobacterium tuberculosis. Semin. Immunol. 26, 431–444.
Couvin, D. and Rastogi, N. 2015. Tuberculosis -a global emergency: Tools and methods to monitor, understand, and control the epidemic with specific example of the bei**g lineage. Tuberculosis (Edinb.). 95 Suppl 1, S177–S189.
De Jong, B.C., Hill, P.C., Aiken, A., Awine, T., Antonio, M., Adetifa, I.M., Jackson-Sillah, D.J., Fox, A., Deriemer, K., Gagneux, S., et al. 2008. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in the gambia. J. Infect. Dis. 198, 1037–1043.
Detjen, A.K., DiNardo, A.R., Leyden, J., Steingart, K.R., Menzies, D., Schiller, I., Dendukuri, N., and Mandalakas, A.M. 2015. Xpert MTB/Rif assay for the diagnosis of pulmonary tuberculosis in children: A systematic review and meta-analysis. Lancet Respir. Med. 3, 451–461.
Devi, K.R., Bhutia, R., Bhowmick, S., Mukherjee, K., Mahanta, J., and Narain, K. 2015. Genetic diversity of Mycobacterium tuberculosis isolates from Assam, India: Dominance of bei**g family and discovery of two new clades related to CAS1_Delhi and EAI family based on spoligoty** and MIRU-VNTR ty**. PLoS One 10, e0145860.
Dheda, K., Davids, V., Lenders, L., Roberts, T., Meldau, R., Ling, D., Brunet, L., van Zyl Smit, R., Peter, J., Green, C., et al. 2010. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 5, e9848.
Ernst, J.D. 2012. The immunological life cycle of tuberculosis. Nat. Rev. Immunol. 12, 581–591.
Ford, C.B., Shah, R.R., Maeda, M.K., Gagneux, S., Murray, M.B., Cohen, T., Johnston, J.C., Gardy, J., Lipsitch, M., and Fortune, S.M. 2013. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat. Genet. 45, 784–790.
Gagneux, S. 2013. Genetic diversity in Mycobacterium tuberculosis. Curr. Top. Microbiol. Immunol. 374, 1–25.
Gagneux, S., DeRiemer, K., Van, T., Kato-Maeda, M., de Jong, B.C., Narayanan, S., Nicol, M., Niemann, S., Kremer, K., Gutierrez, M.C., et al. 2006. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103, 2869–2873.
Galagan, J.E. 2014. Genomic insights into tuberculosis. Nat. Rev. Genet. 15, 307–320.
Glynn, J.R., Whiteley, J., Bifani, P.J., Kremer, K., and van Soolingen, D. 2002. Worldwide occurrence of Bei**g/W strains of Mycobacterium tuberculosis: A systematic review. Emerg. Infect. Dis. 8, 843–849.
Groenen, P.M., Bunschoten, A.E., van Soolingen, D., and van Embden, J.D. 1993. Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel ty** method. Mol. Microbiol. 10, 1057–1065.
Han, S.J., Song, T., Cho, Y.J., Kim, J.S., Choi, S.Y., Bang, H.E., Chun, J., Bai, G.H., Cho, S.N., and Shin, S.J. 2015. Complete genome sequence of Mycobacterium tuberculosis K from a korean high school outbreak, belonging to the Bei**g family. Stand. Genomic Sci. 10, 78.
Hatherill, M., Tait, D., and McShane, H. 2016. Clinical testing of tuberculosis vaccine candidates. Microbiol. Spectr. 4, 5.
Henao-Tamayo, M., Shanley, C.A., Verma, D., Zilavy, A., Stapleton, M.C., Furney, S.K., Podell, B., and Orme, I.M. 2015. The efficacy of the BCG vaccine against newly emerging clinical strains of Mycobacterium tuberculosis. PLoS One 10, e0136500.
Hirsh, A.E., Tsolaki, A.G., DeRiemer, K., Feldman, M.W., and Small, P.M. 2004. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc. Natl. Acad. Sci. USA 101, 4871–4876.
Ismail, A., Teh, L.K., Ngeow, Y.F., Norazmi, M.N., Zainul, Z.F., Tang, T.H., Najimudin, N., and Salleh, M.Z. 2013. Draft genome sequence of a clinical isolate of Mycobacterium tuberculosis strain PR05. Genome Announc. 1, 3.
Jeon, B.Y., Derrick, S.C., Lim, J., Kolibab, K., Dheenadhayalan, V., Yang, A.L., Kreiswirth, B., and Morris, S.L. 2008. Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice. Infect. Immun. 76, 5173–5180.
Kato-Maeda, M., Metcalfe, J.Z., and Flores, L. 2011. Genoty** of Mycobacterium tuberculosis: Application in epidemiologic studies. Future Microbiol. 6, 203–216.
Kim, Y., Choi, Y., Jeon, B.Y., **, H., Cho, S.N., and Lee, H. 2013. A simple and efficient multiplex PCR assay for the identification of Mycobacterium genus and Mycobacterium tuberculosis complex to the species level. Yonsei Med. J. 54, 1220–1226.
Koch, R. 1882. Die Ätiologie der Tuberkulose. Berliner Klin Wochenschr 19, 221–230.
Krishnan, N., Malaga, W., Constant, P., Caws, M., Tran, T.H., Salmons, J., Nguyen, T.N., Nguyen, D.B., Daffe, M., Young, D.B., et al. 2011. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS One 6, e23870.
Lalvani, A. and Pareek, M. 2010. Interferon gamma release assays: Principles and practice. Enferm. Infecc. Microbiol. Clin. 28, 245–252.
Lanzas, F., Karakousis, P.C., Sacchettini, J.C., and Ioerger, T.R. 2013. Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South Africa. J. Clin. Microbiol. 51, 3277–3285.
McShane, H. and Williams, A. 2014. A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data. Tuberculosis (Edinb). 94, 105–110.
Merker, M., Blin, C., Mona, S., Duforet-Frebourg, N., Lecher, S., Willery, E., Blum, M.G., Rusch-Gerdes, S., Mokrousov, I., Aleksic, E., et al. 2015. Evolutionary history and global spread of the Mycobacterium tuberculosis Bei**g lineage. Nat. Genet. 47, 242–249.
Mihret, A., Bekele, Y., Loxton, A.G., Aseffa, A., Howe, R., and Walzl, G. 2012. Plasma level of IL-4 differs in patients infected with different modern lineages of M. tuberculosis. J. Trop. Med. 2012, 518564.
Mokrousov, I., Otten, T., Filipenko, M., Vyazovaya, A., Chrapov, E., Limeschenko, E., Steklova, L., Vyshnevskiy, B., and Narvskaya, O. 2002. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol. 40, 2509–2512.
Morgan, M., Kalantri, S., Flores, L., and Pai, M. 2005. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: A systematic review and metaanalysis. BMC Infect. Dis. 5, 62.
Mostowy, S., Cousins, D., and Behr, M.A. 2004a. Genomic interrogation of the dassie bacillus reveals it as a unique RD1 mutant within the Mycobacterium tuberculosis complex. J. Bacteriol. 186, 104–109.
Mostowy, S., Onipede, A., Gagneux, S., Niemann, S., Kremer, K., Desmond, E.P., Kato-Maeda, M., and Behr, M. 2004b. Genomic analysis distinguishes Mycobacterium africanum. J. Clin. Microbiol. 42, 3594–3599.
Mutingwende, I., Vermeulen, U., Steyn, F., Viljoen, H., and Grobler, A. 2015. Development and evaluation of a rapid multiplex-PCR based system for Mycobacterium tuberculosis diagnosis using sputum samples. J. Microbiol. Methods 116, 37–43.
Nakajima, C., Tamaru, A., Rahim, Z., Poudel, A., Maharjan, B., Khin Saw, A., Ling, H., Hattori, T., Iwamoto, T., Fukushima, Y., et al. 2013. Simple multiplex PCR assay for identification of Bei**g family Mycobacterium tuberculosis isolates with a lineage-specific mutation in Rv0679c. J. Clin. Microbiol. 51, 2025–2032.
Newton, S.M., Smith, R.J., Wilkinson, K.A., Nicol, M.P., Garton, N.J., Staples, K.J., Stewart, G.R., Wain, J.R., Martineau, A.R., Fandrich, S., et al. 2006. A deletion defining a common asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc. Natl. Acad. Sci. USA 103, 15594–15598.
Nguyen, V.A., Banuls, A.L., Tran, T.H., Pham, K.L., Nguyen, T.S., Nguyen, H.V., Nguyen, N.L., Nguyen, N.L., Dang, D.A., Marks, G.B., et al. 2016. Mycobacterium tuberculosis lineages and antituberculosis drug resistance in reference hospitals across Viet Nam. BMC Microbiol. 16, 167.
Nicol, M.P. and Wilkinson, R.J. 2008. The clinical consequences of strain diversity in Mycobacterium tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 102, 955–965.
Niemann, S. and Supply, P. 2014. Diversity and evolution of Mycobacterium tuberculosis: Moving to whole-genome-based approaches. Cold Spring Harb. Perspect. Med. 4, a021188.
Oelemann, M.C., Diel, R., Vatin, V., Haas, W., Rusch-Gerdes, S., Locht, C., Niemann, S., and Supply, P. 2007. Assessment of an optimized mycobacterial interspersed repetitive-unit-variablenumber tandem-repeat ty** system combined with spoligoty** for population-based molecular epidemiology studies of tuberculosis. J. Clin. Microbiol. 45, 691–697.
Perez-Osorio, A.C., Boyle, D.S., Ingham, Z.K., Ostash, A., Gautom, R.K., Colombel, C., Houze, Y., and Leader, B.T. 2012. Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing. J. Clin. Microbiol. 50, 326–336.
Portevin, D., Gagneux, S., Comas, I., and Young, D. 2011. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 7, e1001307.
Reiling, N., Homolka, S., Walter, K., Brandenburg, J., Niwinski, L., Ernst, M., Herzmann, C., Lange, C., Diel, R., Ehlers, S., et al. 2013. Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice. mBio 4, e00250–13.
Ribeiro, S.C., Gomes, L.L., Amaral, E.P., Andrade, M.R., Almeida, F.M., Rezende, A.L., Lanes, V.R., Carvalho, E.C., Suffys, P.N., Mokrousov, I., et al. 2014. Mycobacterium tuberculosis strains of the modern sublineage of the Bei**g family are more likely to display increased virulence than strains of the ancient sublineage. J. Clin. Microbiol. 52, 2615–2624.
Rook, G.A., Bahr, G.M., and Stanford, J.L. 1981. The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle. 62, 63–68.
Rose, G., Cortes, T., Comas, I., Coscolla, M., Gagneux, S., and Young, D.B. 2013. Map** of genotype-phenotype diversity among clinical isolates of Mycobacterium tuberculosis by sequence-based transcriptional profiling. Genome Biol. Evol. 5, 1849–1862.
Sarkar, R., Lenders, L., Wilkinson, K.A., Wilkinson, R.J., and Nicol, M.P. 2012. Modern lineages of Mycobacterium tuberculosis exhibit lineage-specific patterns of growth and cytokine induction in human monocyte-derived macrophages. PLoS One 7, e43170.
Sarmiento, O.L., Weigle, K.A., Alexander, J., Weber, D.J., and Miller, W.C. 2003. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J. Clin. Microbiol. 41, 3233–3240.
Sinha, P., Gupta, A., Prakash, P., Anupurba, S., Tripathi, R., and Srivastava, G.N. 2016. Differentiation of Mycobacterium tuberculosis complex from non-tubercular mycobacteria by nested multiplex PCR targeting IS6110, MTP40 and 32kD alpha antigen encoding gene fragments. BMC Infect. Dis. 16, 123.
Smith, N.H., Kremer, K., Inwald, J., Dale, J., Driscoll, J.R., Gordon, S.V., van Soolingen, D., Hewinson, R.G., and Smith, J.M. 2006. Ecotypes of the Mycobacterium tuberculosis complex. J. Theor. Biol. 239, 220–225.
Sreevatsan, S., Pan, X., Stockbauer, K.E., Connell, N.D., Kreiswirth, B.N., Whittam, T.S., and Musser, J.M. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA 94, 9869–9874.
Starke, J.R. 2014. Interferon-gamma release assays for diagnosis of tuberculosis infection and disease in children. Pediatr. 134, e1763–e1773.
Tevere, V.J., Hewitt, P.L., Dare, A., Hocknell, P., Keen, A., Spadoro, J.P., and Young, K.K. 1996. Detection of Mycobacterium tuberculosis by PCR amplification with pan-Mycobacterium primers and hybridization to an M. tuberculosis-specific probe. J. Clin. Microbiol. 34, 918–923.
Thierry, D., Brisson-Noel, A., Vincent-Levy-Frebault, V., Nguyen, S., Guesdon, J.L., and Gicquel, B. 1990. Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis. J. Clin. Microbiol. 28, 2668–2673.
Thwaites, G., Caws, M., Chau, T.T., D'Sa, A., Lan, N.T., Huyen, M.N., Gagneux, S., Anh, P.T., Tho, D.Q., Torok, E., et al. 2008. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J. Clin. Microbiol. 46, 1363–1368.
Tortoli, E., Urbano, P., Marcelli, F., Simonetti, T.M., and Cirillo, D.M. 2012. Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples? J. Clin. Microbiol. 50, 2810–2813.
Tsolaki, A.G., Gagneux, S., Pym, A.S., Goguet de la Salmoniere, Y.O., Kreiswirth, B.N., Van Soolingen, D., and Small, P.M. 2005. Genomic deletions classify the Bei**g/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J. Clin. Microbiol. 43, 3185–3191.
Victor, T.C., de Haas, P.E., Jordaan, A.M., van der Spuy, G.D., Richardson, M., van Soolingen, D., van Helden, P.D., and Warren, R. 2004. Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype. J. Clin. Microbiol. 42, 769–772.
Viratyosin, W., Kulawonganunchai, S., Smittipat, N., Juthayothin, T., Penpassakarn, P., Pasomsub, E., Chantratita, W., Chaiprasert, A., and Palittapongarnpim, P. 2013. Draft genome sequence of the Mycobacterium tuberculosis strain 43-16836, belonging to the Indo-Oceanic lineage, isolated from tuberculous meningitis in Thailand. Genome Announc. 1, e00801–13.
Wang, C., Peyron, P., Mestre, O., Kaplan, G., van Soolingen, D., Gao, Q., Gicquel, B., and Neyrolles, O. 2010. Innate immune response to Mycobacterium tuberculosis Bei**g and other genotypes. PLoS One 5, e13594.
Warren, R.M., van der Spuy, G.D., Richardson, M., Beyers, N., Borgdorff, M.W., Behr, M.A., and van Helden, P.D. 2002. Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease. J. Clin. Microbiol. 40, 1705–1708.
Weniger, T., Krawczyk, J., Supply, P., Niemann, S., and Harmsen, D. 2010. MIRU-VNTRplus: A web tool for polyphasic genoty** of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res. 38, W326–W331.
Winglee, K., Manson McGuire, A., Maiga, M., Abeel, T., Shea, T., Desjardins, C.A., Diarra, B., Baya, B., Sanogo, M., Diallo, S., et al. 2016. Whole genome sequencing of Mycobacterium africanum strains from Mali provides insights into the mechanisms of geographic restriction. PLoS Negl. Trop. Dis. 10, e0004332.
World Health Organization. 2016. Global tuberculosis report 2016.
Yimer, S.A., Hailu, E., Derese, Y., Bjune, G.A., and Holm-Hansen, C. 2013. Spoligoty** of Mycobacterium tuberculosis isolates among pulmonary tuberculosis patients in Amhara Region, Ethiopia. Acta Pathol. Microbiol. Immunol. Scand. 121, 878–885.
Zhang, L., Ru, H.W., Chen, F.Z., **, C.Y., Sun, R.F., Fan, X.Y., Guo, M., Mai, J.T., Xu, W.X., Lin, Q.X., et al. 2016. Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms. Mol. Ther. 24, 398–405.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chae, H., Shin, S.J. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development. J Microbiol. 56, 300–311 (2018). https://doi.org/10.1007/s12275-018-8041-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-018-8041-3